title: [Treatment of acute attack of migraine with sumatriptan].
abstract: BACKGROUND
  In the Hospital Clínico Quirúrgico Hermanos Almeijeiras a randomized double blind clinical trial was carried out involving 52 patients who presented with painful migraine crises with or without prodromes. A group of 27 patients were given 6 mg of sumatriptan subcutaneously. Another group of 25 patients were given 1 mg of dihydroergotamine intramuscularly. It was seen that both drugs relieved the migrainous pain. However, sumatriptan did so in a greater percentage of patients.
  
  
  CONCLUSIONS
  There was earlier, and also more complete, relief of pain in those patients receiving sumatriptan. With regard to side-effects of sumatriptan were pain at the back of the site of injection, sensation of pressure at the back of the neck, facial flushing and asthenia.
authors.affiliation: Servicio de Neurología, Hospital C.Q. Hermanos Ameijeiras, Ciudad de La Habana, Cuba.
authors.forename: L E
authors.initials: LE
authors.lastname: González-Espinosa
authors.forename: N
authors.initials: N
authors.lastname: Gómez-Viera
authors.forename: I
authors.initials: I
authors.lastname: Olivera-Leal
authors.forename: R
authors.initials: R
authors.lastname: Reyes-Lorente
mesh_terms: D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D017677:Age Distribution; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D008881:Migraine Disorders / Q000175:diagnosis / Q000188:drug therapy*; D017366:Serotonin Receptor Agonists / Q000627:therapeutic use*; D012720:Severity of Illness Index; D017678:Sex Distribution; D018170:Sumatriptan / Q000627:therapeutic use*; D013997:Time Factors
chemical_list: D017366:Serotonin Receptor Agonists; D018170:Sumatriptan
vernacular_title: Tratamiento del ataque agudo de la cefalea migrañosa con sumatriptán.